The tool is now available on the company’s PatientMetRx platform. The company licensed the GPT models from Microsoft, according to a May 11 Talking Medicines news release.
“We are really excited by the potential of Drug-GPT to transform the way that healthcare advertising agencies analyze insights on complex patient and healthcare professionals’ social data,” Talking Medicines co-founder and CEO Jo Halliday said in the release. “With structured and actionable insights delivered within seconds, it provides our customers with the edge to win business, create amazing content, and deliver successful campaigns. With Drug-GPT and PatientMetRx 2.0, we truly believe we can unlock the power of AI to transform healthcare marketing.”
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
